Technology · 4 views
Synchron Pauses Trials of Its Brain Implant Due to Performance Issues
Brain implant company Synchron has paused clinical trials of its second-generation device after it failed to perform as expected in initial study participants, WIRED has learned.
Summary
Brain implant company Synchron has paused clinical trials of its second-generation device after it failed to perform as expected in initial study participants, WIRED has learned. The Brooklyn-based startup, a competitor to Elon Musk’s Neuralink , is also undergoing a restructuring, which includes eliminating jobs and scaling back its footprint in New York while building up a team in San Diego to support the development of an entirely new device.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Technology
Continue reading recent Technology coverage
- Jensen Huang is out. What did China want from him?Continue reading
- Read Nvidia’s internal emails about the ‘extraordinarily difficult period’ amid CEO shakeupContinue reading
- Nvidia CEO Jensen Huang Resigns, Creating a ‘Stress Test for the AI Boom’Continue reading
- United Airlines wants you to check in, not your chatbotContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow